Public Policy Letters, Statements, Legal Briefs, & Other Responses
-
ACMG Comments to CMS about Proposed Decision for Medicare Coverage of NGS for Advanced Cancer
-
Group Letter to Congress Supporting the Newborn Screening Saves Lives Reauthorization Act (NBSSLRA) of 2019
-
ACMG Comments to CMS Regarding NCD 90.2 and Medicare Coverage of NGS for Advanced Cancer
-
Group Sign-on Letter to CMS Requesting Extension of Comment Period Regarding NGS Coverage Reconsideration
-
Group Sign-on Letter to CMS Requesting Revision of Interpretation of NCD for NGS for Advanced Cancer
-
Group Sign-on Letter to Congress (House) Requesting FY 2019 Appropriations for Newborn Screening Programs
-
Group Sign-on Letter to Congress (Senate) Requesting FY 2019 Appropriations for Newborn Screening Programs
-
Group Sign-on Letter to Congress Requesting FY 2019 Appropriations for the National Institute of Child Health and Human Development (NICHD)
-
ACMG Responds to FDA’s Approval for DTC Testing for Three BRCA Gene Mutations
-
ACMG Comments to CMS on Proposed NCD for Coverage of NGS for Medicare Beneficiaries with Advanced Cancer (CAG-00450N)